Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
- Status
- COMPLETED
- Phase
- PHASE2
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study
- Status
- COMPLETED
- Phase
- PHASE4
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
- Status
- COMPLETED
- Phase
- NA
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
ATP and P2X3 Receptor in Chronic Cough
- Status
- UNKNOWN
- Phase
- NA
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
- Status
- COMPLETED
- Phase
- PHASE2
An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy
- Status
- COMPLETED
- Phase
- NA
IMM60 and Pembrolizumab in Melanoma and NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
- Status
- RECRUITING
- Phase
- PHASE2
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
- Status
- RECRUITING
- Phase
- N/A
MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)
- Status
- COMPLETED
- Phase
- PHASE1